BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Craig CM, Liu LF, Deacon CF, Holst JJ, McLaughlin TL. Critical role for GLP-1 in symptomatic post-bariatric hypoglycaemia. Diabetologia 2017;60:531-40. [PMID: 27975209 DOI: 10.1007/s00125-016-4179-x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 56] [Article Influence: 10.5] [Reference Citation Analysis]
Number Citing Articles
1 Mulla CM, Zavitsanou S, Laguna Sanz AJ, Pober D, Richardson L, Walcott P, Arora I, Newswanger B, Cummins MJ, Prestrelski SJ, Doyle FJ, Dassau E, Patti ME. A Randomized, Placebo-Controlled Double-Blind Trial of a Closed-Loop Glucagon System for Postbariatric Hypoglycemia. J Clin Endocrinol Metab 2020;105:dgz197. [PMID: 31714583 DOI: 10.1210/clinem/dgz197] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
2 Hindsø M, Svane MS, Hedbäck N, Holst JJ, Madsbad S, Bojsen-Møller KN. The role of GLP-1 in postprandial glucose metabolism after bariatric surgery: a narrative review of human GLP-1 receptor antagonist studies. Surg Obes Relat Dis 2021;17:1383-91. [PMID: 33771461 DOI: 10.1016/j.soard.2021.01.041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Scarpellini E, Arts J, Karamanolis G, Laurenius A, Siquini W, Suzuki H, Ukleja A, Van Beek A, Vanuytsel T, Bor S, Ceppa E, Di Lorenzo C, Emous M, Hammer H, Hellström P, Laville M, Lundell L, Masclee A, Ritz P, Tack J. International consensus on the diagnosis and management of dumping syndrome. Nat Rev Endocrinol 2020;16:448-66. [PMID: 32457534 DOI: 10.1038/s41574-020-0357-5] [Cited by in Crossref: 57] [Cited by in F6Publishing: 33] [Article Influence: 28.5] [Reference Citation Analysis]
4 Laguna Sanz AJ, Mulla CM, Fowler KM, Cloutier E, Goldfine AB, Newswanger B, Cummins M, Deshpande S, Prestrelski SJ, Strange P, Zisser H, Doyle FJ 3rd, Dassau E, Patti ME. Design and Clinical Evaluation of a Novel Low-Glucose Prediction Algorithm with Mini-Dose Stable Glucagon Delivery in Post-Bariatric Hypoglycemia. Diabetes Technol Ther 2018;20:127-39. [PMID: 29355439 DOI: 10.1089/dia.2017.0298] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
5 Müller TD, Finan B, Bloom SR, D'Alessio D, Drucker DJ, Flatt PR, Fritsche A, Gribble F, Grill HJ, Habener JF, Holst JJ, Langhans W, Meier JJ, Nauck MA, Perez-Tilve D, Pocai A, Reimann F, Sandoval DA, Schwartz TW, Seeley RJ, Stemmer K, Tang-Christensen M, Woods SC, DiMarchi RD, Tschöp MH. Glucagon-like peptide 1 (GLP-1). Mol Metab 2019;30:72-130. [PMID: 31767182 DOI: 10.1016/j.molmet.2019.09.010] [Cited by in Crossref: 212] [Cited by in F6Publishing: 204] [Article Influence: 70.7] [Reference Citation Analysis]
6 Arman GA, Himpens J, Bolckmans R, Van Compernolle D, Vilallonga R, Leman G. Medium-Term Outcomes after Reversal of Roux-en-Y Gastric Bypass. Obes Surg 2018;28:781-90. [PMID: 28929425 DOI: 10.1007/s11695-017-2928-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
7 Leutner M, Klimek P, Göbl C, Bozkurt L, Harreiter J, Husslein P, Eppel W, Baumgartner-Parzer S, Pacini G, Thurner S, Kautzky-Willer A. Glucagon-like peptide 1 (GLP-1) drives postprandial hyperinsulinemic hypoglycemia in pregnant women with a history of Roux-en-Y gastric bypass operation. Metabolism 2019;91:10-7. [PMID: 30448278 DOI: 10.1016/j.metabol.2018.10.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
8 Sinclair P, Docherty N, le Roux CW. Metabolic Effects of Bariatric Surgery. Clinical Chemistry 2018;64:72-81. [DOI: 10.1373/clinchem.2017.272336] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.8] [Reference Citation Analysis]
9 Svane MS, Toft-Nielsen MB, Kristiansen VB, Hartmann B, Holst JJ, Madsbad S, Bojsen-Møller KN. Nutrient re-routing and altered gut-islet cell crosstalk may explain early relief of severe postprandial hypoglycaemia after reversal of Roux-en-Y gastric bypass. Diabet Med 2017;34:1783-7. [PMID: 28782840 DOI: 10.1111/dme.13443] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
10 Mulla CM, Goldfine AB, Dreyfuss JM, Houten S, Pan H, Pober DM, Wewer Albrechtsen NJ, Svane MS, Schmidt JB, Holst JJ, Craig CM, McLaughlin TL, Patti ME. Plasma FGF-19 Levels are Increased in Patients with Post-Bariatric Hypoglycemia. Obes Surg 2019;29:2092-9. [PMID: 30976983 DOI: 10.1007/s11695-019-03845-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
11 Elliott JA, Docherty NG, Murphy CF, Eckhardt HG, Doyle SL, Guinan EM, Ravi N, Reynolds JV, le Roux CW. Changes in gut hormones, glycaemic response and symptoms after oesophagectomy. Br J Surg 2019;106:735-46. [PMID: 30883706 DOI: 10.1002/bjs.11118] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
12 Holst JJ, Albrechtsen NJW, Rosenkilde MM, Deacon CF. Physiology of the Incretin Hormones, GIP and GLP ‐1—Regulation of Release and Posttranslational Modifications. In: Terjung R, editor. Comprehensive Physiology. Wiley; 2011. pp. 1339-81. [DOI: 10.1002/cphy.c180013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
13 Larraufie P, Roberts GP, McGavigan AK, Kay RG, Li J, Leiter A, Melvin A, Biggs EK, Ravn P, Davy K, Hornigold DC, Yeo GSH, Hardwick RH, Reimann F, Gribble FM. Important Role of the GLP-1 Axis for Glucose Homeostasis after Bariatric Surgery. Cell Rep 2019;26:1399-1408.e6. [PMID: 30726726 DOI: 10.1016/j.celrep.2019.01.047] [Cited by in Crossref: 61] [Cited by in F6Publishing: 52] [Article Influence: 30.5] [Reference Citation Analysis]
14 Gilijamse PW, Demirkiran A, van Wagensveld BA, Ackermans MT, Romijn JA, Nieuwdorp M, Ter Horst KW, Serlie MJ. The relation between postprandial glucagon-like peptide-1 release and insulin sensitivity before and after bariatric surgery in humans with class II/III obesity. Surg Obes Relat Dis 2021;17:1440-8. [PMID: 34083134 DOI: 10.1016/j.soard.2021.04.022] [Reference Citation Analysis]
15 Holst JJ. Treatment of Type 2 Diabetes and Obesity on the Basis of the Incretin System: The 2021 Banting Medal for Scientific Achievement Award Lecture. Diabetes 2021;70:2468-75. [PMID: 34711671 DOI: 10.2337/dbi21-0026] [Reference Citation Analysis]
16 Martinussen C, Veedfald S, Dirksen C, Bojsen-møller KN, Svane MS, Wewer Albrechtsen NJ, van Hall G, Kristiansen VB, Fenger M, Holst JJ, Madsbad S. The effect of acute dual SGLT1/SGLT2 inhibition on incretin release and glucose metabolism after gastric bypass surgery. American Journal of Physiology-Endocrinology and Metabolism 2020;318:E956-64. [DOI: 10.1152/ajpendo.00023.2020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
17 Hong S, Park B, Noh H, Choi DJ. Herbal Medicine for Dumping Syndrome: A Systematic Review and Meta-Analysis. Integr Cancer Ther 2019;18:1534735419873404. [PMID: 31549529 DOI: 10.1177/1534735419873404] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
18 Tharakan G, Behary P, Wewer Albrechtsen NJ, Chahal H, Kenkre J, Miras AD, Ahmed AR, Holst JJ, Bloom SR, Tan T. Roles of increased glycaemic variability, GLP-1 and glucagon in hypoglycaemia after Roux-en-Y gastric bypass. Eur J Endocrinol 2017;177:455-64. [PMID: 28855269 DOI: 10.1530/EJE-17-0446] [Cited by in Crossref: 27] [Cited by in F6Publishing: 14] [Article Influence: 5.4] [Reference Citation Analysis]
19 Roberts G, Hardwick R, Fitzgerald RC. Decision making, quality of life and prophylactic gastrectomy in carriers of pathogenic CDH1 mutations. Transl Gastroenterol Hepatol 2017;2:21. [PMID: 28447056 DOI: 10.21037/tgh.2017.03.12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
20 Marques AR, Lobato CB, Pereira SS, Guimarães M, Faria S, Nora M, Monteiro MP. Insights from the Impact of Meal Composition on Glucose Profile Towards Post-bariatric Hypoglycemia Management. Obes Surg 2020;30:249-55. [PMID: 31435901 DOI: 10.1007/s11695-019-04147-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
21 Honka H, Salehi M. Postprandial hypoglycemia after gastric bypass surgery: from pathogenesis to diagnosis and treatment. Curr Opin Clin Nutr Metab Care 2019;22:295-302. [PMID: 31082828 DOI: 10.1097/MCO.0000000000000574] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 8.5] [Reference Citation Analysis]
22 Douros JD, Tong J, D'Alessio DA. The Effects of Bariatric Surgery on Islet Function, Insulin Secretion, and Glucose Control. Endocr Rev 2019;40:1394-423. [PMID: 31241742 DOI: 10.1210/er.2018-00183] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 12.0] [Reference Citation Analysis]
23 Evers SS, Kim KS, Bozadjieva N, Lewis AG, Farris D, Sorensen MJ, Kim Y, Whitesall SE, Kennedy RT, Michele DE, Seeley RJ, Sandoval DA. Continuous glucose monitoring reveals glycemic variability and hypoglycemia after vertical sleeve gastrectomy in rats. Mol Metab 2020;32:148-59. [PMID: 32029224 DOI: 10.1016/j.molmet.2019.12.011] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Suhl E, Anderson-Haynes SE, Mulla C, Patti ME. Medical nutrition therapy for post-bariatric hypoglycemia: practical insights. Surg Obes Relat Dis 2017;13:888-96. [PMID: 28392017 DOI: 10.1016/j.soard.2017.01.025] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 6.8] [Reference Citation Analysis]
25 Schönenberger KA, Cossu L, Prendin F, Cappon G, Wu J, Fuchs KL, Mayer S, Herzig D, Facchinetti A, Bally L. Digital Solutions to Diagnose and Manage Postbariatric Hypoglycemia. Front Nutr 2022;9:855223. [DOI: 10.3389/fnut.2022.855223] [Reference Citation Analysis]
26 Tan M, Lamendola C, Luong R, Mclaughlin T, Craig C. Safety, efficacy and pharmacokinetics of repeat subcutaneous dosing of avexitide (exendin 9‐39) for treatment of post‐bariatric hypoglycaemia. Diabetes Obes Metab 2020;22:1406-16. [DOI: 10.1111/dom.14048] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
27 Yaqub A, Smith EP, Salehi M. Hyperinsulinemic hypoglycemia after gastric bypass surgery: what's up and what's down? Int J Obes (Lond) 2017. [PMID: 29087389 DOI: 10.1038/ijo.2017.257] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
28 Holst JJ, Pedersen J, Wewer Albrechtsen NJ, Knop FK. The Gut: A Key to the Pathogenesis of Type 2 Diabetes? Metab Syndr Relat Disord 2017;15:259-62. [PMID: 28605280 DOI: 10.1089/met.2017.0015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
29 Craig CM, Lawler HM, Lee CJE, Tan M, Davis DB, Tong J, Glodowski M, Rogowitz E, Karaman R, McLaughlin TL, Porter L. PREVENT: A Randomized, Placebo-controlled Crossover Trial of Avexitide for Treatment of Postbariatric Hypoglycemia. J Clin Endocrinol Metab 2021;106:e3235-48. [PMID: 33616643 DOI: 10.1210/clinem/dgab103] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Zanley E, Shah ND, Craig C, Lau JN, Rivas H, McLaughlin T. Guidelines for gastrostomy tube placement and enteral nutrition in patients with severe, refractory hypoglycemia after gastric bypass. Surg Obes Relat Dis 2021;17:456-65. [PMID: 33160876 DOI: 10.1016/j.soard.2020.09.026] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Lobato CB, Pereira SS, Guimarães M, Hartmann B, Wewer Albrechtsen NJ, Hilsted L, Holst JJ, Nora M, Monteiro MP. A Potential Role for Endogenous Glucagon in Preventing Post-Bariatric Hypoglycemia. Front Endocrinol (Lausanne) 2020;11:608248. [PMID: 33424773 DOI: 10.3389/fendo.2020.608248] [Reference Citation Analysis]
32 Zhou LY, Deng MQ, Xiao XH. Potential contribution of the gut microbiota to hypoglycemia after gastric bypass surgery. Chin Med J (Engl) 2020;133:1834-43. [PMID: 32649508 DOI: 10.1097/CM9.0000000000000932] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
33 Tsai C, Steffen R, Kessler U, Merki H, Zehetner J. Short-term outcomes of endoscopic gastro-jejunal revisions for treatment of dumping syndrome after Roux-En-Y gastric bypass. Surg Endosc 2020;34:3626-32. [PMID: 31552507 DOI: 10.1007/s00464-019-07137-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
34 Emous M, Wolffenbuttel BH, van Dijk G, Totté E, van Beek AP. Long-term self-reported symptom prevalence of early and late dumping in a patient population after sleeve gastrectomy, primary, and revisional gastric bypass surgery. Surgery for Obesity and Related Diseases 2018;14:1173-81. [DOI: 10.1016/j.soard.2018.04.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
35 Bienvenot R, Sirveaux MA, Nguyen-Thi PL, Brunaud L, Quilliot D. Symptomatic Hypoglycemia After Gastric Bypass: Incidence and Predictive Factors in a Cohort of 1,138 Consecutive Patients. Obesity (Silver Spring) 2021;29:681-8. [PMID: 33608995 DOI: 10.1002/oby.23118] [Reference Citation Analysis]
36 Suzuki R, Brown GA, Christopher JA, Scully CCG, Congreve M. Recent Developments in Therapeutic Peptides for the Glucagon-like Peptide 1 and 2 Receptors. J Med Chem 2020;63:905-27. [PMID: 31577440 DOI: 10.1021/acs.jmedchem.9b00835] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
37 Wauters L, Vanuytsel T. Applications of peptide hormone ligands for the treatment of dumping and short bowel syndrome. Current Opinion in Pharmacology 2018;43:118-23. [DOI: 10.1016/j.coph.2018.09.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
38 Rogowitz E, Patti ME, Lawler HM. Time to Dump Late Dumping Syndrome Terminology. Obes Surg 2019;29:2985-6. [PMID: 31227985 DOI: 10.1007/s11695-019-04033-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Zhou M, Wang L, Zhou L, Chang X, Zhu X. Novel Insight into the Mechanism of Metabolic Surgery Causing the Diversity in Glycemic Status in Type 2 Diabetes. Exp Clin Endocrinol Diabetes 2022. [PMID: 34979572 DOI: 10.1055/a-1708-3214] [Reference Citation Analysis]
40 Davis DB, Khoraki J, Ziemelis M, Sirinvaravong S, Han JY, Campos GM. Roux en Y gastric bypass hypoglycemia resolves with gastric feeding or reversal: Confirming a non-pancreatic etiology. Mol Metab 2018;9:15-27. [PMID: 29449181 DOI: 10.1016/j.molmet.2017.12.011] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 6.8] [Reference Citation Analysis]
41 Brunet E, Caixàs A, Puig V. Review of the management of diarrhea syndrome after a bariatric surgery. Endocrinol Diabetes Nutr (Engl Ed) 2020;67:401-7. [PMID: 31843494 DOI: 10.1016/j.endinu.2019.09.013] [Reference Citation Analysis]
42 Salehi M, Gastaldelli A, D'Alessio DA. Beta-cell sensitivity to insulinotropic gut hormones is reduced after gastric bypass surgery. Gut 2019;68:1838-45. [PMID: 30772836 DOI: 10.1136/gutjnl-2018-317760] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
43 Craig CM, McLaughlin TL. Defining clinically important hypoglycemia in patients with postbariatric hypoglycemia. Surg Obes Relat Dis 2021:S1550-7289(21)00310-5. [PMID: 34275761 DOI: 10.1016/j.soard.2021.06.013] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Søeby M, Nielsen JB, Pedersen SB, Gribsholt SB, Holst JJ, Richelsen B. Relationship between biochemical and symptomatic hypoglycemia after RYGB. Responses to a mixed meal test: a case-control study. Surgery for Obesity and Related Diseases 2020;16:1179-85. [DOI: 10.1016/j.soard.2020.04.024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
45 Gasbjerg LS, Bergmann NC, Stensen S, Christensen MB, Rosenkilde MM, Holst JJ, Nauck M, Knop FK. Evaluation of the incretin effect in humans using GIP and GLP-1 receptor antagonists. Peptides 2020;125:170183. [DOI: 10.1016/j.peptides.2019.170183] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
46 Shah A, Prasad M, Mark V, Holst JJ, Laferrère B. Glucagon-like peptide-1 effect on β-cell function varies according to diabetes remission status after Roux-en-Y gastric bypass. Diabetes Obes Metab 2022. [PMID: 35676799 DOI: 10.1111/dom.14793] [Reference Citation Analysis]
47 Gribble FM, Reimann F, Roberts GP. Gastrointestinal Hormones ☆. Physiology of the Gastrointestinal Tract. Elsevier; 2018. pp. 31-70. [DOI: 10.1016/b978-0-12-809954-4.00002-5] [Cited by in Crossref: 11] [Article Influence: 2.8] [Reference Citation Analysis]
48 Kay RG, Foreman RE, Roberts GP, Hardwick R, Reimann F, Gribble FM. Mass spectrometric characterisation of the circulating peptidome following oral glucose ingestion in control and gastrectomised patients. Rapid Commun Mass Spectrom 2020;34:e8849. [PMID: 32492232 DOI: 10.1002/rcm.8849] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
49 Craig CM, Liu LF, Nguyen T, Price C, Bingham J, McLaughlin TL. Efficacy and pharmacokinetics of subcutaneous exendin (9-39) in patients with post-bariatric hypoglycaemia. Diabetes Obes Metab 2018;20:352-61. [PMID: 28776922 DOI: 10.1111/dom.13078] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
50 Hepprich M, Antwi K, Waser B, Reubi JC, Wild D, Christ ER. Brunner's Gland Hyperplasia in a Patient after Roux-Y Gastric Bypass: An Important Pitfall in GLP-1 Receptor Imaging. Case Rep Endocrinol 2020;2020:4510910. [PMID: 32313706 DOI: 10.1155/2020/4510910] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
51 Blackstone RP. Comment on: Reversal of Roux-en-Y gastric bypass: largest single-institution experience. Surgery for Obesity and Related Diseases 2019;15:1316-8. [DOI: 10.1016/j.soard.2019.06.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
52 Mariën I, De Block C, Verrijken A, Van Dessel K, Peiffer F, Verhaegen A, Hubens G, Van Gaal L, Dirinck E. Features of oral glucose tolerance tests in patients after Roux‐en‐Y gastric bypass with and without hypoglycaemia symptoms in daily life: It's all about speed. Diabetes Obes Metab 2020;22:2107-19. [DOI: 10.1111/dom.14130] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
53 Lobato CB, Pereira SS, Guimarães M, Morais T, Oliveira P, de Carvalho JPM, Nora M, Monteiro MP. Use of flash glucose monitoring for post-bariatric hypoglycaemia diagnosis and management. Sci Rep 2020;10:11061. [PMID: 32632211 DOI: 10.1038/s41598-020-68029-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
54 Salehi M, Vella A, McLaughlin T, Patti ME. Hypoglycemia After Gastric Bypass Surgery: Current Concepts and Controversies. J Clin Endocrinol Metab. 2018;103:2815-2826. [PMID: 30101281 DOI: 10.1210/jc.2018-00528] [Cited by in Crossref: 61] [Cited by in F6Publishing: 51] [Article Influence: 20.3] [Reference Citation Analysis]
55 Smith EP, Polanco G, Yaqub A, Salehi M. Altered glucose metabolism after bariatric surgery: What's GLP-1 got to do with it? Metabolism 2018;83:159-66. [DOI: 10.1016/j.metabol.2017.10.014] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
56 Hutch CR, Sandoval D. The Role of GLP-1 in the Metabolic Success of Bariatric Surgery. Endocrinology 2017;158:4139-51. [PMID: 29040429 DOI: 10.1210/en.2017-00564] [Cited by in Crossref: 70] [Cited by in F6Publishing: 64] [Article Influence: 14.0] [Reference Citation Analysis]
57 Papamargaritis D, le Roux CW. Do Gut Hormones Contribute to Weight Loss and Glycaemic Outcomes after Bariatric Surgery? Nutrients 2021;13:762. [PMID: 33652862 DOI: 10.3390/nu13030762] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
58 Heller SR, Pratley RE, Sinclair A, Festa A, Kiljański J, Brusko CS, Duan R, Heine RJ. Glycaemic outcomes of an Individualized treatMent aPproach for oldER vulnerable patIents: A randomized, controlled stUdy in type 2 diabetes Mellitus (IMPERIUM). Diabetes Obes Metab 2018;20:148-56. [PMID: 28671753 DOI: 10.1111/dom.13051] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
59 Gasbjerg LS, Bari EJ, Christensen M, Knop FK. Exendin(9-39)NH2 : Recommendations for clinical use based on a systematic literature review. Diabetes Obes Metab 2021. [PMID: 34351033 DOI: 10.1111/dom.14507] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
60 Kandel D, Bojsen-møller KN, Svane MS, Samkani A, Astrup A, Holst JJ, Madsbad S, Krarup T. Mechanisms of action of a carbohydrate-reduced, high-protein diet in reducing the risk of postprandial hypoglycemia after Roux-en-Y gastric bypass surgery. The American Journal of Clinical Nutrition 2019;110:296-304. [DOI: 10.1093/ajcn/nqy310] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
61 Davis EM, Sandoval DA. Glucagon‐Like Peptide‐1: Actions and Influence on Pancreatic Hormone Function. In: Terjung R, editor. Comprehensive Physiology. Wiley; 2011. pp. 577-95. [DOI: 10.1002/cphy.c190025] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
62 Elvert R, Bossart M, Herling AW, Weiss T, Zhang B, Kannt A, Wagner M, Haack T, Evers A, Dudda A, Keil S, Lorenz M, Lorenz K, Riz M, Hennerici W, Larsen PJ. Team Players or Opponents: Coadministration of Selective Glucagon and GLP-1 Receptor Agonists in Obese Diabetic Monkeys. Endocrinology 2018;159:3105-19. [PMID: 29992313 DOI: 10.1210/en.2018-00399] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]